Bartlett & Co’s Regeneron Pharmaceuticals REGN Stock Holding History

Bartlett & Co’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$303K	Hold	344	–	–	﹤0.01%	413
2023 Q3	$283K	Hold	344	–	–	0.01%	405
2023 Q2	$247K	Hold	344	–	–	﹤0.01%	426
2023 Q1	$283K	Hold	344	–	–	0.01%	347
2022 Q4	$248K	Hold	344	–	–	0.01%	353
2022 Q3	$237K	Hold	344	–	–	0.01%	352
2022 Q2	$203K	Hold	344	–	–	﹤0.01%	371
2022 Q1	$240K	Hold	344	–	–	﹤0.01%	366
2021 Q4	$217K	Hold	344	–	–	﹤0.01%	382
2021 Q3	$208K	Sell	344 -9	-3%	-$5.59K	﹤0.01%	331
2021 Q2	$197K	Hold	353	–	–	﹤0.01%	334
2021 Q1	$167K	Hold	353	–	–	﹤0.01%	344
2020 Q4	$171K	Buy	353 +9	+3%	+$4.86K	﹤0.01%	341
2020 Q3	$193K	Hold	344	–	–	﹤0.01%	313
2020 Q2	$215K	Buy	344 +135	+65%	+$76.6K	0.01%	303
2020 Q1	$102K	Buy	+209	New	+$86.2K	﹤0.01%	367
2019 Q3	$58K	Buy	209 +168	+410%	+$49.7K	﹤0.01%	502
2019 Q2	$13K	Buy	41 +1	+3%	+$333	﹤0.01%	570
2019 Q1	$16K	Hold	40	–	–	﹤0.01%	538
2018 Q4	$15K	Hold	40	–	–	﹤0.01%	543
2018 Q3	$16K	Hold	40	–	–	﹤0.01%	565
2018 Q2	$14K	Hold	40	–	–	﹤0.01%	569
2018 Q1	$14K	Hold	40	–	–	﹤0.01%	575
2017 Q4	$15K	Sell	40 -15	-27%	-$6.08K	﹤0.01%	553
2017 Q3	$25K	Hold	55	–	–	﹤0.01%	509
2017 Q2	$27K	Hold	55	–	–	﹤0.01%	501
2017 Q1	$21K	Buy	+55	New	+$20.4K	﹤0.01%	534

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bartlett & Co's REGN Position: Q4 2023 in Review

Bartlett & Co held its Regeneron Pharmaceuticals (REGN) position steady in Q4 2023 at 344 shares worth $303K. The position accounts for ﹤0.01% of the portfolio, ranked #413.

Bartlett & Co first reported a position in REGN in Q1 2017 and has held it in 27 quarters since. 1,272 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

Bartlett & Co held 344 shares of Regeneron Pharmaceuticals worth $303K as of Q4 2023.
Bartlett & Co left its Regeneron Pharmaceuticals share count unchanged in Q4 2023.
Regeneron Pharmaceuticals made up ﹤0.01% of Bartlett & Co's portfolio in Q4 2023, its #413 holding.
Bartlett & Co first reported a position in Regeneron Pharmaceuticals in Q1 2017 and has held it in 27 quarters since.
1,272 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Bartlett & Co's 13F filing for Q4 2023, filed 8 Jan 2024.